Josephine Harrington, MD

Assistant Professor, Medicine-Cardiology

Faculty Photo
Medical School
  • MD, University of Massachusetts Medical School
Undergraduate School
  • BA/BS, University of Massachusetts–Amherst (MA)
Internship
  • University of Texas Southwestern Medical School Program
Residency
  • University of Texas Southwestern Medical School Program, Internal Medicine
Fellowships
  • Duke University Hospital Program, Cardiology
  • Duke University Hospital Program, Advanced Heart Failure and Transplant Cardiology
Languages
English
Department
Medicine-Cardiology

Publications

  • Costa TA, Felix N, Chagas GCL, Teran S, Boslough M, Shelar V, Lee MMY, Pandey A, Abreu M, McGuire DK, Harrington J. Incretin-based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2025 Sep;27(9):4747-4753. PubMed PMID: 40497333
  • Rafei AE, Harrington JA, Tavares CAM, Guimarães PO, Ambrosy AP, Bonaca MP, Sauer AJ, Vardeny O, Canonico ME. Heart failure with preserved ejection fraction therapeutics: in search of the pillars. Heart Fail Rev. 2025 Sep;30(5):1005-1014. PubMed PMID: 40399553
  • Vest AR, Ilonze OJ, Umapathi P, Harrington J. Body Composition and Treatment Response in Heart Failure With Preserved Ejection Fraction: Interpreting the Adipokine Hypothesis. J Am Coll Cardiol. 2025 Oct 21;86(16):1256-1259. PubMed PMID: 41093493
  • Harrington JL, Canonico ME, El Rafei A, Solomon SD, Teerlink JR, Vaduganathan M, Zieroth SR, Bonaca MP, Sauer AJ. Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions. JACC Heart Fail. 2025 Oct;13(10):102637. PubMed PMID: 40886449
  • Kittipibul V, Cyr DD, Harrington J, Lala A, Fudim M, Ward JH, Sarwat S, Solomon SD, Hernandez AF, Zieroth S, Starling RC, Mentz RJ. Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trial. Am Heart J. 2025 Nov;289:105-116. PubMed PMID: 40412494
  • Costa TA, Harrington JL. Advances in the management of obesity and heart failure: latest evidence from clinical trials. Curr Opin Cardiol. 2025 May 1;40(3):164-171. PubMed PMID: 39998461
  • Harrington J, Alpert MA. Obesity and Heart Failure in Patients With a Reduced Ejection Fraction: Two True and Unrelated?. JACC Heart Fail. 2025 May;13(5):737-739. PubMed PMID: 40208139
  • Aggarwal R, Bhatt DL, Hernandez AF, Anker SD, Harrington J, Jones WS, Mattheus M, Petrie MC, Steubl D, Sumin M, Thanam V, Udell JA, Butler J. Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction. Nat Cardiovasc Res. 2025 Jun;4(6):761-772. PubMed PMID: 40514435
  • Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V. Asundexian versus Apixaban in Patients with Atrial Fibrillation. N Engl J Med. 2025 Jan 2;392(1):23-32. PubMed PMID: 39225267
  • Chang AJ, Liang Y, Girouard MP, Bhatt AS, Sandhu AT, Sauer AJ, Greene SJ, Harrington J, Go AS, Ambrosy AP. Changing the paradigm in heart failure: shifting from treatment to prevention. Heart Fail Rev. 2025 Jan;30(1):177-189. PubMed PMID: 39441333
  • Nouhravesh N, Harrington J, Aberle LH, Green CL, Voss K, Holdsworth D, Misialek K, Slaugh BT, Wieand M, Yancy WS Jr, Pagidipati N, Mentz RJ. Effects of fortified eggs and time-restricted eating on cardiometabolic health: The prosperity trial. Am Heart J. 2025 Jan;279:27-39. PubMed PMID: 39414223
  • Harrington J, McGuire DK, Inzucchi SE. Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists: A One-Two Punch?. JACC Heart Fail. 2024 Nov;12(11):1827-1829. PubMed PMID: 39387772
  • Haller PM, Jarolim P, Palazzolo MG, Bellavia A, Antman EM, Eikelboom J, Granger CB, Harrington J, Healey JS, Hijazi Z, Patel MR, Patel SM, Ruff CT, Wallentin L, Braunwald E, Giugliano RP, Morrow DA. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF. J Am Coll Cardiol. 2024 Oct 15;84(16):1528-1540. PubMed PMID: 39230543
  • Harrington J, Kang YM, McGuire DK. Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost. Diabetes Care. 2024 Nov 1;47(11):1897-1899. PubMed PMID: 39432776
  • Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J. Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. Eur J Heart Fail. 2024 Dec 26. [Epub ahead of print] PubMed PMID: 39725521
  • Harrington J, Leyva M, Rao VN, Oakes M, Osude N, Bosworth HB, Pagidipati NJ. Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators. Am Heart J. 2024 Nov 28;281:23-31. [Epub ahead of print] PubMed PMID: 39613172
  • Reed SD, Harrington JL, Morin DP, Saba SF, Montgomery JA, Harrison RW, Frisch DR, Viethen T, Tamm M, Xiao J, Mundl H, Coppolecchia R, Yang JC, Wallace MJ, Gonzalez JM, Patel MR. Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF Study. JACC Adv. 2024 Dec;3(12):101370. PubMed PMID: 39568653
  • Halaseh R, Sauer AJ, Vardeny O, Canonico ME, Harrington J, Svetlichnaya J, Ambrosy AP. A fine addition: Finerenone in the evolving landscape of heart failure with preserved ejection fraction. Heart Fail Rev. 2024 Oct 30. [Epub ahead of print] PubMed PMID: 39476221
  • Harrington J, Gale SE, Vest AR. Anti-Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance. Circ Heart Fail. 2024 Sep;17(9):e011518. PubMed PMID: 39087359
  • Karpurapu A, Williams HA, DeBenedittis P, Baker CE, Ren S, Thomas MC, Beard AJ, Devlin GW, Harrington J, Parker LE, Smith AK, Mainsah B, Pla MM, Asokan A, Bowles DE, Iversen E, Collins L, Karra R. Deep Learning Resolves Myovascular Dynamics in the Failing Human Heart. JACC Basic Transl Sci. 2024 May;9(5):674-686. PubMed PMID: 38984052
  • Harrington J. Anti-obesity medications in the management of heart failure with preserved ejection fraction: available evidence and next STEPS. Heart Fail Rev. 2024 Sep;29(5):939-944. PubMed PMID: 38965119
  • Nouhravesh N, Garg J, Rockhold FW, De Pasquale CG, O'Meara E, Lewis GD, Butler J, Harrington J, Ezekowitz JA, Ponikowski P, Troughton RW, Wong YW, Blackman N, Numan S, Adamczyk R, Hernandez AF, Mentz RJ. Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. Eur J Heart Fail. 2024 Jun 19. [Epub ahead of print] PubMed PMID: 38896006
  • Harrington J. STEP HFpEF DM: a sweet sequel. Heart Fail Rev. 2024 Sep;29(5):913-915. PubMed PMID: 38888653
  • Medina CK, Barnes SG, Felker GM, Mentz RJ, Pagidipati NJ, Seymour KA, Schroder JN, Harrington J. Severe obesity among patients with left ventricular assist devices. Am Heart J. 2024 Aug;274:130-133. PubMed PMID: 38866442
  • Harrington J, Hellkamp AS, Mahaffey KW, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Fox KAA, Singer DE, Goodman SG, Patel MR, Piccini JP. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. J Am Heart Assoc. 2024 Jun 4;13(11):e028951. PubMed PMID: 38780169
  • Peters AE, Clare RM, Chiswell K, Harrington J, Kelsey A, Hernandez A, Felker GM, Mentz RJ, DeVore AD. Implications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction. ESC Heart Fail. 2024 Oct;11(5):2813-2824. PubMed PMID: 38757437
  • Greene SJ, Chambers R, Lerman JB, Harrington J, deFilippi CR, Wendell DC, Kim HW, Green CL, Butler J, Felker GM. Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial. Eur J Heart Fail. 2024 Jun;26(6):1393-1398. PubMed PMID: 38733160
  • Harrington J, Felker GM, Lingvay I, Pagidipati NJ, Pandey A, McGuire DK. Managing Obesity in Heart Failure: A Chance to Tip the Scales?. JACC Heart Fail. 2024 Jan;12(1):28-34. PubMed PMID: 37897462
  • Harrington J, Rao VN, Leyva M, Oakes M, Mentz RJ, Bosworth HB, Pagidipati NJ. Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies. J Card Fail. 2024 Feb;30(2):376-390. PubMed PMID: 38142886
  • Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Storie T, Blackman N, Hernandez AF. Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial. Circ Heart Fail. 2024 Feb;17(2):e010676. PubMed PMID: 38250799
  • Harrington J, Felker GM, Januzzi JL, Lam CSP, Lingvay I, Pagidipati NJ, Sattar N, Van Spall HGC, Verma S, McGuire DK. Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions. Curr Cardiol Rep. 2024 Mar;26(3):61-71. PubMed PMID: 38551786
  • Sattar N, Butler J, Lee MMY, Harrington J, Sharma A, Zannad F, Filippatos G, Verma S, Januzzi JL, Ferreira JP, Pocock SJ, Pfarr E, Ofstad AP, Brueckmann M, Packer M, Anker SD. Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial. Eur J Heart Fail. 2024 Apr;26(4):900-909. PubMed PMID: 38558521
  • Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, A Figtree G, Ge J, G Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation. 2024 May 21;149(21):1627-1638. PubMed PMID: 38581389
  • Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, Mattheus M, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF. Empagliflozin after Acute Myocardial Infarction. N Engl J Med. 2024 Apr 25;390(16):1455-1466. PubMed PMID: 38587237
  • Udell JA, Petrie MC, Jones WS, Anker SD, Harrington J, Mattheus M, Seide S, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Martinez-Traba M, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J. Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction. J Am Coll Cardiol. 2024 Jun 11;83(23):2233-2246. PubMed PMID: 38588929
  • Harrington J, Sattar N, Felker GM, Januzzi JL, Lam CSP, Pagidipati NJ, Pandey A, Van Spall HGC, McGuire DK. Putting More Weight on Obesity Trials in Heart Failure. Curr Heart Fail Rep. 2024 Jun;21(3):194-202. PubMed PMID: 38619690
  • Harrington J, McCrary AW, Nguyen M, Nyandiko W, Barker PCA, Koech M, Thielman NM, Muehlbauer MJ, Shah SH, Bloomfield GS. Proteomics discovery in children and young adults with HIV identifies fibrosis, inflammatory, and immune biomarkers associated with myocardial impairment. AIDS. 2024 Jun 1;38(7):1090-1093. PubMed PMID: 38691053
  • Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, She L, Harrington J, Adamczyk R, Blackman N, Hernandez AF. Ferric Carboxymaltose in Heart Failure with Iron Deficiency. N Engl J Med. 2023 Sep 14;389(11):975-986. PubMed PMID: 37632463
  • Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Andersen KR, Sumin M, Zwiener I, Hernandez AF, Butler J. Baseline characteristics of patients enrolled in the EMPACT-MI trial. Eur J Heart Fail. 2023 Sep;25(9):1708-1715. PubMed PMID: 37622416
  • Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene SJ. Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure. Am J Cardiol. 2023 Oct 15;205:524-526. PubMed PMID: 37666729
  • Benz AP, Hohnloser SH, Eikelboom JW, Carnicelli AP, Giugliano RP, Granger CB, Harrington J, Hijazi Z, Morrow DA, Patel MR, Seiffge DJ, Shoamanesh A, Wallentin L, Yi Q, Connolly SJ. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. Eur Heart J. 2023 May 21;44(20):1807-1814. PubMed PMID: 37038327
  • Harrington J, Sun JL, Fonarow GC, Heitner SB, Divanji PH, Binder G, Allen LA, Alhanti B, Yancy CW, Albert NM, DeVore AD, Felker GM, Greene SJ. Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction. J Am Heart Assoc. 2023 May 16;12(10):e028820. PubMed PMID: 37158118
  • Harrington J, Carnicelli AP, Hua K, Wallentin L, Patel MR, Hohnloser SH, Giugliano RP, Fox KAA, Hijazi Z, Lopes RD, Pokorney SD, Hong H, Granger CB. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF. Circulation. 2023 Jun 6;147(23):1748-1757. PubMed PMID: 37042255
  • Harrington J, Nixon AB, Daubert MA, Yow E, Januzzi J, Fiuzat M, Whellan DJ, O'Connor CM, Ezekowitz J, Piña IL, Adams KF, Felker GM, Karra R. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure. J Card Fail. 2023 Jun;29(6):896-906. PubMed PMID: 36632934
  • Harrington J, Mentz RJ. Ironing out the wrinkles: Unanswered questions in intravenous iron repletion in heart failure. Eur J Heart Fail. 2023 Jul;25(7):1091-1093. PubMed PMID: 37191130
  • Aliyev N, Almani MU, Qudrat-Ullah M, Harrington J, Fonarow GC, Butler J, Pandey A, Khan MS, Greene SJ. Neighborhood Household Income and Trends in 30-Day Readmission for Patients With Heart Failure. JACC Heart Fail. 2023 Jan;11(1):121-123. PubMed PMID: 36357301
  • Cosiano MF, Vista A, Sun JL, Alhanti B, Harrington J, Butler J, Starling RC, Mentz RJ, Greene SJ. Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. Circ Heart Fail. 2023 Jan;16(1):e010107. PubMed PMID: 36314126
  • Harrington J, Piccini JP, Alexander JH, Granger CB, Patel MR. Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Feb 28;81(8):771-779. PubMed PMID: 36813377
  • Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Blackman N, Hernandez AF. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. Am Heart J. 2023 Dec;266:25-31. PubMed PMID: 37598795
  • Goodwin NP, Clare RM, Harrington JL, Badjatiya A, Wojdyla DM, Udell JA, Butler J, Januzzi JL Jr, Parikh PB, James S, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Hernandez AF, Jones WS. Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials. J Card Fail. 2023 Dec;29(12):1603-1614. PubMed PMID: 37479054
  • Harrington J, Butler J. Heart failure after myocardial infarction: Glass emptier than full. Eur J Heart Fail. 2023 Aug;25(8):1225-1227. PubMed PMID: 37462280
  • Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Böhm M, Greene SJ, Felker GM, Vaduganathan M, Butler J. Medication-Attributable Adverse Events in Heart Failure Trials. JACC Heart Fail. 2023 Apr;11(4):425-436. PubMed PMID: 36881395
  • Harrington J, Petrie MC, Anker SD, Bhatt DL, Jones WS, Udell JA, Hernandez AF, Butler J. Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review. JAMA Cardiol. 2022 Oct 1;7(10):1067-1075. PubMed PMID: 36044233
  • Nelson AJ, Harrington JL, Kolkailah AA, Pagidipati NJ, McGuire DK. Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events. Heart Fail Clin. 2022 Oct;18(4):597-607. PubMed PMID: 36216489
  • Harrington J, Anker S, Butler J. Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure. Eur Heart J. 2022 Nov 1;43(41):4433-4435. PubMed PMID: 36036745
  • Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Vedin O, Sumin M, Zwiener I, Hernandez AF, Butler J. Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. Am Heart J. 2022 Nov;253:86-98. PubMed PMID: 35595091
  • Udell JA, Jones WS, Petrie MC, Harrington J, Anker SD, Bhatt DL, Hernandez AF, Butler J. Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 May 24;79(20):2058-2068. PubMed PMID: 35589167
  • Harrington J, Tseliou E, Shah S, Shah KS. Paying Homage to the Power of Proteomics: Insights Into Obesity and Heart Failure From the HOMAGE Trial. J Card Fail. 2022 May;28(5):787-788. PubMed PMID: 35304349
  • Harrington J, Jones WS, Udell JA, Hannan K, Bhatt DL, Anker SD, Petrie MC, Vedin O, Butler J, Hernandez AF. Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome. JACC Heart Fail. 2022 Jun;10(6):404-414. PubMed PMID: 35654525
  • Harrington J, Felker GM. Leveraging Multiple Biomarkers to Assess Risk of Acute Heart Failure: Is More Better?. J Card Fail. 2022 Feb;28(2):234-236. PubMed PMID: 34952784
  • Harrington J, Gouda P, Ezekowitz J, Mentz RJ. Exploring the pragmatic-explanatory spectrum across cardiovascular clinical trials. Contemp Clin Trials. 2022 Feb;113:106646. PubMed PMID: 34863929
  • Harrington J, Granger CB. Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem. Eur Heart J. 2022 Dec 14;43(47):4909-4911. PubMed PMID: 36380455
  • Peters AE, Mentz RJ, Sun JL, Harrington JL, Fudim M, Alhanti B, Hernandez AF, Butler J, Starling RC, Greene SJ. Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction. J Card Fail. 2022 Dec;28(12):1652-1660. PubMed PMID: 35688408
  • Harrington J, Felker GM, Mentz RJ. Catastrophic Disruptions in Clinical Trials. Circulation. 2022 Aug 2;146(5):369-371. PubMed PMID: 35914015
  • Harrington J, Mentz RJ. Prioritizing Quad Therapy and the Path Forward in Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction. Circulation. 2022 Apr 12;145(15):1105-1107. PubMed PMID: 35404676
  • Piccini JP, Harrington J. Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?. J Am Coll Cardiol. 2022 Apr 12;79(14):1382-1384. PubMed PMID: 35393019
  • Harrington JL, Granger CB. Standardizing ST-Segment Elevation Myocardial Infarction Care: Customizing Regionalization to Improve Outcomes. Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007701. PubMed PMID: 33641340
View All (67 Total) View Less

Practice Locations

UCHealth Heart & Vascular Center - Anschutz
12505 E. 16th Ave
Anschutz Inpatient Pavilion 2, 3rd floor
Aurora, CO 80045
720-848-5300

Hospital Affiliation
  • University of Colorado Hospital

Center Affiliations

Specialty Information

Specialties
  • Cardiology, Board Certification
  • Advanced Heart Failure and Transplant Cardiology, Board Certification
  • Obesity Medicine, Board Certification
Conditions & Treatments
  • Heart and Circulation - Cardiomyopathy
  • Heart and Circulation
  • Heart and Circulation - Heart Failure
Clinical Interests
My clinical interests include heart failure with preserved ejection fraction, obesity, and cardiometabolic disease

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Campus Box C290

Aurora, CO 80045


303.724.5375